| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| PRADAXA 75mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52942003 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 75mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52942004 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 6,25 mg/ml | DABIGATRANUM ETEXILATUM | PULB. + SOLV. PT. SOL. ORALA | B01AE07 | W69043001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 50 mg | DABIGATRANUM ETEXILATUM | GRANULE DRAJEFIATE | B01AE07 | W69040001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 40 mg | DABIGATRANUM ETEXILATUM | GRANULE DRAJEFIATE | B01AE07 | W69039001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 30 mg | DABIGATRANUM ETEXILATUM | GRANULE DRAJEFIATE | B01AE07 | W69038001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 20 mg | DABIGATRANUM ETEXILATUM | GRANULE DRAJEFIATE | B01AE07 | W69037001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 150mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W57151001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 150mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W57151002 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 150mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W57151003 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 150mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W57151004 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 150mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W57151005 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 150 mg | DABIGATRANUM ETEXILATUM | GRANULE DRAJEFIATE | B01AE07 | W69042001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 110mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52943001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 110mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52943002 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 110mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52943003 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 110mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52943004 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 110mg | DABIGATRANUM ETEXILATUM | CAPS. | B01AE07 | W52943005 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PRADAXA 110 mg | DABIGATRANUM ETEXILATUM | GRANULE DRAJEFIATE | B01AE07 | W69041001 | BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA | X | |||||
| PPD TUBERCULIN MAMMALIAN 5 TU/0,1 ml | TUBERCULINUM | SOL. INJ. | V04CF01 | W69510001 | CN UNIFARM S.A. - ROMANIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman